-
Founded in:
2002-07-19 -
Country:
China -
Address:
East Suburb of Huixian City, Henan Province -
Tax NO.:
91410782740724979U -
Registered Funds:
39.58 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vitamin B6 |
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.
More
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin. |
10mg | 8059-24-3 | 13 |
| Starch |
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.
More
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin. |
9005-25-8 | 78 | |
| Dextrin |
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.
More
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin. |
9004-53-9 | 50 | |
| Magnesium stearate |
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.
More
Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin. |
557-04-0 | 61 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diphenoxylate |
No specific description of pharmacological action is provided
More
No specific description of pharmacological action is provided |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diltiazem hydrochloride |
This product is a calcium channel blocker, and its action is related to the inhibition of calcium ion influx during myocardial and vascular smooth muscle depolarization. This product can effectively dilate the epicardial and subendocardial coronary arteries, relieve spontaneous angina pectoris or angina pectoris caused by coronary artery spasm induced by ergonovine; by slowing down the heart rate and lowering blood pressure, it reduces myocardial oxygen demand, increases exercise tolerance and relieves exertional angina pectoris. This product can relax vascular smooth muscle, reduce peripheral vascular resistance, and lower blood pressure; the extent of its blood pressure reduction is related to the degree of hypertension, and only slightly reduces blood pressure in people with normal blood pressure. This product has a negative inotropic effect and can slow down the conduction of the sinoatrial node and atrioventricular node.
More
This product is a calcium channel blocker, and its action is related to the inhibition of calcium ion influx during myocardial and vascular smooth muscle depolarization. This product can effectively dilate the epicardial and subendocardial coronary arteries, relieve spontaneous angina pectoris or angina pectoris caused by coronary artery spasm induced by ergonovine; by slowing down the heart rate and lowering blood pressure, it reduces myocardial oxygen demand, increases exercise tolerance and relieves exertional angina pectoris. This product can relax vascular smooth muscle, reduce peripheral vascular resistance, and lower blood pressure; the extent of its blood pressure reduction is related to the degree of hypertension, and only slightly reduces blood pressure in people with normal blood pressure. This product has a negative inotropic effect and can slow down the conduction of the sinoatrial node and atrioventricular node. |
33286-22-5 | 41 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Etamsylate |
It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.
More
It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect. |
2624-44-4 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ribavirin |
Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.
More
Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus. |
36791-04-5 | 33 |